Figure 5.
Diabetic severe COVID-19 patients have greater frequencies of CD62L+ T cells. The frequencies of CD4+ (A) and CD8+ T cells (viable, CD14-, CD56-, CD19-, CD3+, CD4+ or CD8+ cells) (B) expressing CD62L in severe and non-severe COVID-19 patients with or without diabetes were assessed by flow cytometry. *p<0.05, **p<0.01 one-way ANOVA with multiple comparisons correction.